KR101245440B1 - 사이토킨 조절물질 및 관련된 용도 - Google Patents

사이토킨 조절물질 및 관련된 용도 Download PDF

Info

Publication number
KR101245440B1
KR101245440B1 KR1020067003492A KR20067003492A KR101245440B1 KR 101245440 B1 KR101245440 B1 KR 101245440B1 KR 1020067003492 A KR1020067003492 A KR 1020067003492A KR 20067003492 A KR20067003492 A KR 20067003492A KR 101245440 B1 KR101245440 B1 KR 101245440B1
Authority
KR
South Korea
Prior art keywords
composition
extract
wild rose
fruit
blackberry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020067003492A
Other languages
English (en)
Korean (ko)
Other versions
KR20070028276A (ko
Inventor
러셀 케이. 란돌프
해리 노-슈미트
메리 에이. 머레이
아론 더블유. 크로포드
케빈 더블유. 젤렌베크
도날드 제이. 푸사테리
Original Assignee
액세스 비지니스 그룹 인터내셔날 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 액세스 비지니스 그룹 인터내셔날 엘엘씨 filed Critical 액세스 비지니스 그룹 인터내셔날 엘엘씨
Publication of KR20070028276A publication Critical patent/KR20070028276A/ko
Application granted granted Critical
Publication of KR101245440B1 publication Critical patent/KR101245440B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
KR1020067003492A 2003-09-12 2004-09-10 사이토킨 조절물질 및 관련된 용도 Expired - Lifetime KR101245440B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50275503P 2003-09-12 2003-09-12
US60/502,755 2003-09-12
PCT/IB2004/051742 WO2005025586A1 (en) 2003-09-12 2004-09-10 Cytokine modulators and related method of use

Publications (2)

Publication Number Publication Date
KR20070028276A KR20070028276A (ko) 2007-03-12
KR101245440B1 true KR101245440B1 (ko) 2013-03-19

Family

ID=34312420

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067003492A Expired - Lifetime KR101245440B1 (ko) 2003-09-12 2004-09-10 사이토킨 조절물질 및 관련된 용도

Country Status (6)

Country Link
US (1) US7838050B2 (enExample)
JP (1) JP4903569B2 (enExample)
KR (1) KR101245440B1 (enExample)
CN (2) CN1882354B (enExample)
TW (2) TWI358300B (enExample)
WO (1) WO2005025586A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101990000B1 (ko) 2018-03-02 2019-09-30 강원대학교산학협력단 초석잠 뿌리 추출물 또는 이의 분획물을 유효성분으로 포함하는 기능성 조성물

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005025586A1 (en) 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
US7758902B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US20050260290A1 (en) * 2004-05-20 2005-11-24 Rutgers, The State University Of New Jersey Botanical anti-inflammatory compositions and methods
JP4703280B2 (ja) * 2005-06-15 2011-06-15 ポーラ化成工業株式会社 オイル化粧料
CN101291681A (zh) * 2005-08-23 2008-10-22 捷通国际有限公司 细胞因子调节物及相关使用方法
US20070154581A1 (en) * 2005-12-30 2007-07-05 Kumar Kalyani M Composition and method for enhancing or stimulating the immune system
EP2034855A2 (en) * 2006-05-12 2009-03-18 Interleukin Genetics, Inc. Food compositions and methods of treating periodontal disease
JP5170577B2 (ja) * 2006-07-14 2013-03-27 ディーエスエム アイピー アセッツ ビー．ブイ． 炎症障害の治療のためにバラの実および他の活性剤を含んでなる組成物
KR101471215B1 (ko) 2006-10-24 2014-12-09 크렘핀, 로리에 항-재흡수 및 골 형성 식이보충제 및 이의 사용 방법
EP1925301A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders
US7875300B2 (en) * 2006-11-24 2011-01-25 Rutgers, The State University Of New Jersey Methods for reducing circulating glucose levels
JP5372358B2 (ja) * 2007-01-20 2013-12-18 美智士 谷 生体活性治療物質
US20080254110A1 (en) * 2007-04-10 2008-10-16 Marvin Heuer Composition For Enhancing Immunity and Reducing Inflammation Related to Infections
WO2009132463A1 (en) * 2008-05-02 2009-11-05 Neptune Technologies & Bioressources Inc. New deodorization method and organoleptic improvement of marine oil extracts
JP2010013403A (ja) * 2008-07-04 2010-01-21 Kao Corp Ｎｆａｔシグナル阻害剤及びｎｆａｔシグナル阻害方法
KR101326162B1 (ko) * 2009-10-01 2013-11-07 재단법인 제주테크노파크 항염증성 조성물
JP5827625B2 (ja) 2009-10-29 2015-12-02 アカスティ ファーマ インコーポレイテッド 濃縮治療用リン脂質組成物
US8609157B2 (en) 2009-10-30 2013-12-17 Tharos Ltd. Solvent-free process for obtaining phospholipids and neutral enriched krill oils
CN104066434A (zh) * 2012-01-30 2014-09-24 捷通国际有限公司 抗炎和抗氧化组合物和相关使用方法
JP6533639B2 (ja) * 2012-03-16 2019-06-19 株式会社コーセー 皮膚外用剤及び紫外線によるカロテノイド含有油性成分の分解抑制方法
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
US9023399B2 (en) * 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8962041B2 (en) * 2013-02-12 2015-02-24 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for enhancing hair quality using blackberry extract
CN106413732A (zh) 2014-03-14 2017-02-15 新篇章股份有限公司 补充食品
EP3236979A4 (en) * 2014-12-19 2018-08-15 Paradise Health, Inc. Methods for reducing platelet aggregation and treating cardiovascular disease and other medical disorders
US9622498B2 (en) 2015-07-17 2017-04-18 Vera Roasting Company, Inc. Roasted coffee with resveratrol
US20170035789A1 (en) * 2015-08-05 2017-02-09 Bill H. McAnalley Composition Of Dietary Supplements Based On Apoptosis that Support Optimal Health
FR3042413B1 (fr) * 2015-10-20 2019-07-12 Valbiotis Composition comprenant un melange de molecules extraites de chrysanthellum indicum et de cynara scolymus et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
JP7499015B2 (ja) * 2019-10-10 2024-06-13 小林製薬株式会社 神経変性疾患の予防剤及び／又は治療剤
CN114550949A (zh) * 2022-02-28 2022-05-27 首都医科大学附属北京儿童医院 一种儿童药物适口性评价系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980077323A (ko) * 1997-04-18 1998-11-16 손경식 블루베리 과즙과 알파파 증진 음료용 조성물을 함유하는 음료
WO1999053934A1 (en) * 1998-04-17 1999-10-28 HANSEN, Otto, Torbjørn Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US74147A (en) * 1868-02-04 Thomas bosbkugh
US638542A (en) * 1899-06-07 1899-12-05 William w wood Portable boat-motor.
US4110483A (en) * 1977-08-01 1978-08-29 The United States Of America As Represented By The Secretary Of The Army Method of stabilizing foods with an antioxidant
JPH062677B2 (ja) * 1984-05-26 1994-01-12 日産化学工業株式会社 造血臓器回復促進剤
SU1697820A1 (ru) * 1985-09-10 1991-12-15 1-Й Московский Медицинский Институт Им.И.М.Сеченова Средство дл лечени сахарного диабета
DE3784522T2 (de) * 1987-12-23 1993-06-17 Psoricur Ltd Medizinische zusammensetzungen gegen psoriasis.
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
HU213479B (en) 1992-10-08 1997-10-28 Burian Process for producing natural pharmaceutical compositions for preventing and treating diseases of parodontium and gingiva
HU210952B (en) 1992-11-24 1995-09-28 Lenart Process for making a composition containing extract of herbs, and cosmetics containing the composition
JPH0799924A (ja) 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
CN1102993A (zh) * 1993-12-21 1995-05-31 吴文才 多酶体系加工中草药的制剂方法
JPH07300421A (ja) 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
RU2053265C1 (ru) * 1994-09-17 1996-01-27 Лоенко Юрий Николаевич Композиция ингредиентов для бальзама "гомеопат"
US5527533A (en) * 1994-10-27 1996-06-18 Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
UA51613C2 (uk) * 1995-03-06 2002-12-16 Еміль Флахсман Аг Спосіб вилучення небажаних ліпофільних домішок та/або залишків, що містяться в напоях або рослинних препаратах
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US5854291A (en) * 1996-04-23 1998-12-29 Medical Merchandising, Inc. Pain reliever and method of use
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
DK0915693T3 (da) * 1996-08-02 2004-02-09 Plum Kemi Produktion As En olie-i-vand emulsion til brug på menneskers hud for at rengøre, beskytte eller forbedre hudens tilstand
US6642277B1 (en) * 1996-09-20 2003-11-04 The Howard Foundation Food supplements containing polyphenols
US6512848B2 (en) * 1996-11-18 2003-01-28 Canon Kabushiki Kaisha Page analysis system
US5714150A (en) * 1997-01-08 1998-02-03 Nachman; Leslie Method for producing extract of olive leaves
SE522246C2 (sv) 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
US6238675B1 (en) * 1997-02-27 2001-05-29 Campamed Corp. Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals
WO1998045241A2 (en) 1997-04-04 1998-10-15 Henkel Corporation Lutein esters having high bioavailability
US6103218A (en) * 1997-04-23 2000-08-15 Brucker; Donald Therapeutic nasal spray administered composition containing feverfew
FR2766176B1 (fr) * 1997-07-15 1999-10-29 Caudalie Compositions a base de derives de resveratrol
US20030161897A1 (en) * 1997-09-16 2003-08-28 Edward Shanbrom Soluble plant derived natural color concentrates and antimicrobial nutraceuticals
FR2768622B1 (fr) * 1997-09-22 1999-11-26 Oreal Extrait de rosacees en tant qu'antagoniste de bradykinine
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
KR100264773B1 (ko) * 1998-04-02 2000-09-01 윤종용 자기 정렬된 콘택홀을 갖는 반도체 장치의제조 방법
AUPP291598A0 (en) * 1998-04-14 1998-05-07 Allrad 3 Pty Ltd Food supplement
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
US6231866B1 (en) * 1998-04-30 2001-05-15 Douglas G. Mann Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same
US20020168429A1 (en) * 1998-04-30 2002-11-14 Mann Douglas G. Nutritional supplement and method of delivery
US6022901A (en) * 1998-05-13 2000-02-08 Pharmascience Inc. Administration of resveratrol to prevent or treat restenosis following coronary intervention
AU4084599A (en) * 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase
US20020182260A1 (en) * 1998-05-29 2002-12-05 Cellegy Pharmaceuticals, Inc. Anti-inflammatory agents and methods for their preparation and use
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
US20030086986A1 (en) * 1998-08-06 2003-05-08 Bruijn Chris De Ophthalmic, pharmaceutical and other healthcare preparations with naturally occurring plant compounds, extracts and derivatives
US6656925B2 (en) * 1998-09-09 2003-12-02 Advanced Medical Instruments Composition and method of treating arthritis
US6716883B1 (en) * 1998-12-24 2004-04-06 1333366 Ontario Inc. Composition useful to treat periodontal disease
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
EP1100516B1 (en) * 1999-06-03 2005-03-23 Johnson & Johnson Consumer France SAS Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
PT1202743E (pt) * 1999-06-18 2005-02-28 Jon Bragi Bjarnason Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
US6274176B1 (en) * 1999-07-01 2001-08-14 Chromak Research, Inc. Herbal compositions and their use as anti-inflammatory agents for alleviation of arthritis and gout
KR100814297B1 (ko) * 1999-07-09 2008-03-18 썬 팜 코포레이션 악성 종양 및 바이러스 감염을 치료하고 면역 기능을 향상시키기 위한 식이 보충제
KR20060123663A (ko) * 1999-08-27 2006-12-01 미시간 스테이트 유니버시티 천연 사이클로옥시게나제 저해물질을 함유하는 조성물
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
US6358542B2 (en) * 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
ES2157178B1 (es) * 1999-12-23 2002-02-16 Asac Compania De Biotecnologia Procedimiento de obtencion de extractos de olea europaea y aplicaciones de los mismos.
US6238696B1 (en) * 2000-01-07 2001-05-29 Gaia Herbs, Inc. Process for providing herbal medicants in cellulose derivative capsules
US6759062B2 (en) * 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US20010039296A1 (en) * 2000-03-23 2001-11-08 Debasis Bagchi Method and composition for preventing or reducing the symptoms of menopause
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
US7078040B2 (en) * 2000-03-27 2006-07-18 Fuji Chemical Industry Co., Ltd. Method of inhibiting the expression of inflammatory cytokines and chemokines
US20020054924A1 (en) * 2000-04-13 2002-05-09 Leahy Margaret M. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
FR2808190B1 (fr) * 2000-04-28 2002-06-21 Oreal Extrait de vegetal de l'espece vitis vinifera comme inhibiteur de no-synthase et utilisations
US6391345B1 (en) * 2000-05-12 2002-05-21 Tim Heeg Cranberry seed oil, cranberry seed flour and a method for making
CA2412435A1 (en) * 2000-06-13 2001-12-20 Edward A. Lemmo Phytonutrient formula for the relief of chronic pain resulting from inflammation
US6492429B1 (en) * 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
US6333056B1 (en) * 2000-08-14 2001-12-25 Ralph Stanley Robinson Herbal-based pharmaceutical formulations
EP1328282B1 (en) * 2000-08-31 2006-05-31 Phenolics, LLC Efficient method for producing compositions enriched in anthocyanins
US6468541B2 (en) * 2000-08-31 2002-10-22 Chinese Herbal Usa, Inc. Natural, non-allergenic, immune system stimulant
US6485752B1 (en) * 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
DE10153949A1 (de) 2000-11-07 2002-08-01 Engelbert Grzeschik Verwendung von Beerensamenölen
WO2002039956A2 (en) * 2000-11-15 2002-05-23 Rutgers, The State University Of New Jersey Black tea extract for prevention of disease
US20020119173A1 (en) * 2000-12-22 2002-08-29 Lin Samuel Qcheng Cosmetic compositions for preventing skin irritation
US20030190381A1 (en) * 2001-02-02 2003-10-09 Bland Jeffrey S. Medical composition for balancing bodily processes
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US6582736B2 (en) * 2001-03-23 2003-06-24 Terra De Sol Therapeutic oil composition
KR100439209B1 (ko) * 2001-03-30 2004-07-07 남종현 스테미너 증진용 천연차 및 그 제조방법
US6387416B1 (en) * 2001-04-05 2002-05-14 Thomas Newmark Anti-Inflammatory herbal composition and method of use
US20020182270A1 (en) * 2001-05-31 2002-12-05 Stier Roger E. Edible compositions comprising freeze-dried flavoring agents
US20040037903A1 (en) * 2001-06-13 2004-02-26 Lemmo Edward A. Phytonutrient formula for the relief of chronic pain resulting from inflammation
US20030044474A1 (en) * 2001-08-03 2003-03-06 Shaklee Corporation High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
CA2456743A1 (en) * 2001-08-21 2003-02-27 Galileo Pharmaceuticals, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US6638542B2 (en) * 2001-09-20 2003-10-28 Nutricia N.V. Reducing appetite in mammals by administering procyanidin and hydroxycitric acid
US20030108627A1 (en) * 2001-09-25 2003-06-12 Jonathan Selzer Cranberry based dietary supplement and dental hygiene product
US6986906B2 (en) * 2001-09-25 2006-01-17 Herbasway Laboratories, Llc Cranberry based dietary supplement and dental hygiene product
US6464982B1 (en) * 2001-11-02 2002-10-15 Chinese Herbal Usa, Inc. Herbal immune system stimulant
DK1453844T3 (da) * 2001-11-21 2014-02-10 Univ Aarhus Anvendelse af glycosider af mono- og diacylglycerol som anti-inflammatoriske midler
US6713096B2 (en) * 2002-01-04 2004-03-30 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP4477354B2 (ja) * 2002-01-10 2010-06-09 ルピン・リミテッド 乾癬を含む様々な疾患を処置するための薬草組成物、その調製方法およびそのような疾患を処置するための方法
CA2473698A1 (en) 2002-01-16 2003-07-31 Natural Alternatives International, Inc. Anti-inflammatory formulations
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
WO2003103583A2 (en) * 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
US7138129B2 (en) * 2002-07-31 2006-11-21 Melaleuca, Inc. Skin care compositions
US20040109905A1 (en) * 2002-09-18 2004-06-10 Debasis Bagchi Method and composition of anthocyanin-rich berry extracts that prevents or inhibits angiogenesis and helicobacter pylori and acts as a powerful antioxidant that provides various health benefits
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
CA2507704A1 (en) * 2002-12-02 2004-06-17 Mars, Incorporated Flavanols and procyanidins promote homeostasis
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
US20040151761A1 (en) * 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
AU2004273813A1 (en) 2003-09-12 2005-03-31 Access Business Group International Llc Program for regulating health conditions
WO2005025586A1 (en) 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
US20050260290A1 (en) 2004-05-20 2005-11-24 Rutgers, The State University Of New Jersey Botanical anti-inflammatory compositions and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980077323A (ko) * 1997-04-18 1998-11-16 손경식 블루베리 과즙과 알파파 증진 음료용 조성물을 함유하는 음료
WO1999053934A1 (en) * 1998-04-17 1999-10-28 HANSEN, Otto, Torbjørn Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101990000B1 (ko) 2018-03-02 2019-09-30 강원대학교산학협력단 초석잠 뿌리 추출물 또는 이의 분획물을 유효성분으로 포함하는 기능성 조성물

Also Published As

Publication number Publication date
CN1882354A (zh) 2006-12-20
CN102309573A (zh) 2012-01-11
US7838050B2 (en) 2010-11-23
JP4903569B2 (ja) 2012-03-28
TWI358300B (en) 2012-02-21
CN102309573B (zh) 2013-11-20
WO2005025586B1 (en) 2005-05-06
US20050058728A1 (en) 2005-03-17
WO2005025586A1 (en) 2005-03-24
TW201206455A (en) 2012-02-16
JP2007513868A (ja) 2007-05-31
KR20070028276A (ko) 2007-03-12
CN1882354B (zh) 2012-07-04
TW200518765A (en) 2005-06-16

Similar Documents

Publication Publication Date Title
KR101245440B1 (ko) 사이토킨 조절물질 및 관련된 용도
JP2007513868A5 (enExample)
DE69931907T2 (de) Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen
AU2010220058B2 (en) Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome
MXPA04010317A (es) Composiciones para prevenir o tratar polenosis, nefritis alergia, dermatitis atopica, asma o urticaria.
WO2015172608A1 (zh) 一种辅助降血脂的胶囊及其制备方法
Qin et al. Cinnamon polyphenols regulate S100β, sirtuins, and neuroactive proteins in rat C6 glioma cells
Vahid et al. Effect of Capparis spinosa extract on metabolic parameters in patients with type-2 diabetes: a randomized controlled trial
US20140148399A1 (en) Compositions and methods for treating or ameliorating obesity or for reducing diabetic hypercholesterolemia
KR20080041703A (ko) 사이토킨 조절인자 및 관련된 이용 방법
US7758902B2 (en) Cytokine modulators and related methods of use
US7758903B2 (en) Cytokine modulators and related methods of use
CN104363918B (zh) 斐济果果实提取物
WO2019203338A1 (ja) ターメロノールａ及び／又はターメロノールｂを含有する組成物
Lin et al. Total phenolic contents in selected fruit and vegetable juices exhibit a positive correlation with interferon-γ, interleukin-5, and interleukin-2 secretions using primary mouse splenocytes
HK1125563A (en) Cytokine modulators and related methods of use
WO2021002334A1 (ja) ＴＮＦ－α又はＩＬ－６産生抑制用組成物
Fadimatou et al. In vitro antidiabetic potential of two formulated powders of some nutraceutical plants of Cameroon
Musdja et al. Antihyperglycemic Effect and Glucose Tolerance of Ethanol Extract the Rind of Jengkol (Pithecollobium jiringa Jack) in Diabetic Rats
Majdiyyah et al. The Effect of Jeruju Leaf Brew (Acanthus ilicifolius L) on HOMA-IR and TNF-α in White Rats Induce by STZ-NA
HK1098366A (en) Cytokine modulators and related method of use
CN106822114B (zh) Mtca在制备降血糖或降血脂的药物中的用途
Adejuwon et al. Acute effects of Vernonia amygdalina on blood glucose levels in normoglycaemic and alloxan-induced diabetic male Sprague-Dawley rats
Monago et al. Antidiabetic Effects of Crude Flavanoid and Alkaloid of Abrus precatorius Linn Seed in Alloxan Diabetic Rabbits.
EP4653006A1 (en) Novel mixture of active ingredients, compositions containing them, and their use against allergy and/or inflammation

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060221

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20090810

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110512

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20130227

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20130313

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20130313

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20151230

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20151230

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20161229

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20161229

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20171228

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20171228

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20181227

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20181227

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20211229

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20221221

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20240102

Start annual number: 12

End annual number: 12

PC1801 Expiration of term

Termination date: 20250310

Termination category: Expiration of duration